policy

Insurance Tara Bannow

STAT Plus: Insurers hint at suing Biden administration over plans for Medicare Advantage audits

Politics Sarah Owermohle

Still fuming over the federal Covid response, Republicans redirect the House coronavirus committee

Politics Sarah Owermohle

STAT Plus: Rep. Jason Smith and the other Republicans leading health policy in the House

Politics Rachel Cohrs

STAT Plus: 3 drug pricing issues to watch in 2023

Health Lev Facher

3 debates about addiction medicine to watch in 2023

Politics Rachel Cohrs

Pandemic response gets a permanent new home at the White House

Health Andrew Joseph

Under new rules, methadone clinics can offer more take-home doses. Will they?

Insurance Tara Bannow

STAT Plus: Biden administration takes aim at Medicare Advantage care denials, misleading ads

Special Report Rachel Cohrs

STAT Plus: PhRMA, once invincible in Washington, has lost its edge

Politics Rachel Cohrs

In a Republican-led House, probing science agencies tops the agenda

Politics Nicholas Florko

STAT Plus: The FDA has banned certain vapes and medicines. We still bought these 13 products in its backyard

Politics Rachel Cohrs

A Democratic Senate improves the outlook for Biden health and science priorities, including key nominees

Health Care Inc. Bob Herman

Medicare’s midterm punts, MA marketing schemes, and a closer look at the Abiomed deal

Health Ambar Castillo

In Fiona-ravaged Puerto Rico, hospitals were prioritized over health clinics for diesel, exacerbating rural health disparities

Health Tech Mohana Ravindranath

STAT Plus: Health plans say texting could help reach underserved patients. But a federal rule is getting in their way

Health Nicholas Florko

STAT Plus: The U.S. is terrible at keeping businesses from worsening public health, experts say

Insurance Bob Herman

STAT Plus: Errors have plagued insurance directories of doctors. The government wants to clean them up with its own

Politics Bob Herman

STAT Plus: Get a Ph.D. in health policy — from a single Powerpoint slide

Exclusive Rachel Cohrs

STAT Plus: Medicare lays out the bureaucracy it will need to negotiate drug prices

D.C. Diagnosis Sarah Owermohle

Health funding battles, a nutrition policy overhaul, and two CBD developments

Insurance Bob Herman

STAT Plus: Health insurers are painting a misleading picture of Medicare Advantage savings, experts say

Exclusive Rachel Cohrs

STAT Plus: White House pitches drug pricing reforms as a way to extend cancer patients’ lives

Politics Nicholas Florko

STAT Plus: Coors, Mondelez, and other big food companies want to sell CBD-filled food and drinks. The FDA is staunchly opposed

Politics Rachel Cohrs

STAT Plus: Patients for Affordable Drugs taps new leader

Insurance Bob Herman

STAT Plus: Humana appeases Wall Street with big projections of Medicare Advantage growth

A STAT Investigation Nicholas Florko

With a promising new plan to pay for pricey cures, two states set out to eliminate hepatitis C. But cost hasn’t been the biggest problem

First Opinion Blair L. Sadler and Alfred M. Sadler, Jr.

Organ transplantation is at a crossroads. Major reform is needed

First Opinion Linda Richter

THC ingestion by young kids highlights the need to tighten inadequate packaging regulations

Hospitals Tara Bannow

STAT Plus: Medicare wants to stop publishing some hospital safety data next year